The rational design of vaccines

Drug Discovery Today

Volumn 10, Issue 22, 2005, Pages 1527-1534

  Bramwell, Vincent W ^a   Perrie, Yvonne ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTHRAX VACCINE; BACTERIAL VACCINE; BCG VACCINE; CANCER VACCINE; CHOLERA VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DNA VACCINE; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INACTIVATED VIRUS VACCINE; INFLIXIMAB; INFLUENZA VACCINE; LIPOSOME; LIVE VACCINE; MONOCLONAL ANTIBODY; ORAL POLIOMYELITIS VACCINE; POLYGLACTIN; POLYMER; PRAZIQUANTEL; RABIES VACCINE; RITUXIMAB; RUBELLA VACCINE; SMALLPOX VACCINE; SUBUNIT VACCINE; TYPHOID VACCINE; UNINDEXED DRUG; VACCINE; VIROSOME; VIRUS VACCINE;

ALLERGY; AUTOIMMUNE DISEASE; BIOTECHNOLOGY; CANCER; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG DESIGN; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION; MEDICAL RESEARCH; NONHODGKIN LYMPHOMA; NONHUMAN; PASSIVE IMMUNIZATION; PROTOZOAL INFECTION; REVIEW; SCHISTOSOMA MANSONI; SEVERE ACUTE RESPIRATORY SYNDROME; TUBERCULOSIS; VACCINATION;

DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; VACCINES;

EID: 27344445179     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(05)03600-7     Document Type: Review

References (58)

1. Dentico P. Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres Vaccine 20 2002 3725 3730
2. Schmitt H.J. The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine Vaccine 21 2003 3653 3662
3. Ritvo P. Vaccines in the public eye Nat. Med. 11 suppl 4 2005 S20 S24
4. Osterholm M.T. Preparing for the Next Pandemic N. Engl. J. Med. 352 2005 1839 1842
5. Dyer O. WHO's attempts to eradicate polio are thwarted in Africa and Asia BMJ 330 2005 1106
6. Cherkasova E.A. Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine J. Virol. 79 2005 1062 1070
7. Martin J. Long-term excretion of vaccine-derived poliovirus by a healthy child J. Virol. 78 2004 13839 13847
8. Gagliardi M.C. Bacillus Calmette-Guerin shares with virulent Mycobacterium tuberculosis the capacity to subvert monocyte differentiation into dendritic cell: implication for its efficacy as a vaccine preventing tuberculosis Vaccine 22 2004 3848 3857
9. Gutierrez M.G. Autophagy is a defense mechanism inhibiting BCG and mycobacterium tuberculosis survival in infected macrophages Cell 119 2004 753 766
10. Behr M.A. BCG-different strains, different vaccines? Lancet Infect Dis 2 2002 86 92
11. Demissie A. Healthy individuals that control a latent infection with mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4?2 J. Immunol. 172 2004 6938 6943
12. Cooper A.M. Disseminated tuberculosis in interferon gamma gene-disrupted mice J. Exp. Med. 178 1993 2243 2247
13. Flynn J.L. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection J. Exp. Med. 178 1993 2249 2254
14. Price D.A. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection Proc. Natl. Acad. Sci. U. S. A. 94 1997 1890 1895
15. Heeney J.L. Requirement of diverse T-helper responses elicited by HIV vaccines: induction of highly targeted humoral and CTL responses Expert Rev. Vaccines 3 2004 S53 S64
16. Kedl R.M. T cells down-modulate peptide-MHC complexes on APCs in vivo Nat. Immunol. 3 2002 27 32
17. Barthlott T. T Cell Regulation as a side effect of homeostasis and competition J. Exp. Med. 197 2003 451 460
18. Weiss S.T., Raby B.A. Asthma genetics Hum. Mol. Genet. 13 2004 R83 R89
19. Yamada R., Ymamoto K. Recent findings on genes associated with inflammatory disease Mutat. Res. 573 2005 136 151
20. Larche M., Wraith D.C. Peptide-based therapeutic vaccines for allergic and autoimmune diseases Nat. Med. 11 2005 S69 S76
21. Preuss K.D. Analysis of the B-cell repertoire against antigens expressed by human neoplasms Immunol. Rev. 188 2002 43 50
22. Darnell R.B., Posner J.B. Paraneoplastic Syndromes Involving the Nervous System N. Engl. J. Med. 349 2003 1543 1554
23. Stevenson F.K. DNA vaccines to attack cancer Proc. Natl. Acad. Sci. U. S. A. 101 2004 14646 14652
24. Graus F. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients Brain 124 2001 1138 1148
25. Lake R.A., Robinson B.W. Immunotherapy and chemotherapy-a practical partnership Nat. Rev. Cancer 5 2005 397 405
26. Brindley P.J. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens Mol. Biochem. Parasitol. 34 1989 99 108
27. Andersen M.H. Regulators of apoptosis: suitable targets for immune therapy of cancer Nat. Rev. Drug Discov. 4 2005 399 409
28. Pagano J.S. Infectious agents and cancer: criteria for a causal relation Semin. Cancer Biol. 14 2004 453 471
29. Plotkin S.A. Vaccines: past, present and future Nat. Med. 11 2005 S5 S11
30. Plotkin S.A. Six revolutions in vaccinology Pediatr. Infect. Dis. J. 24 2005 1 9
31. Pashine A. Targeting the innate immune response with improved vaccine adjuvants Nat. Med. 11 2005 S63 S68
32. Bramwell V.W., Perrie Y. Particulate delivery systems for vaccines Crit. Rev. Ther. Drug Carrier Syst. 22 2005 151 214
33. Bramwell V.W. Particulate delivery systems for biodefense subunit vaccines Adv. Drug Deliv. Rev. 57 2005 1247 1265
34. Pink J.R., Kieny M.P. 4th Meeting on novel adjuvants currently in/close to human clinical testing: World Health Organization-Organisation Mondiale de la Sante Fondation Merieux, Annecy, France, 23-25 June 2003 Vaccine 22 2004 2097 2102
35. Minor P.D. Eradication and cessation of programmes: vaccination and public health care Br. Med. Bull. 62 2002 213 224
36. Oxman M.N. A Vaccine to prevent herpes zoster and postherpetic neuralgia in older adults N. Engl. J. Med. 352 2005 2271 2284
37. Ying H. Cancer therapy using a self-replicating RNA vaccine Nat. Med. 5 1999 823 827
38. Akira S., Takeda K. Toll-like receptor signalling Nat. Rev. Immunol. 4 2004 499 511
39. Lambert P.H. Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med. 11 2005 S54 S62
40. Alpar H.O., Bramwell V.W. Current status of DNA vaccines and their route of administration Crit. Rev. Ther. Drug Carrier Syst. 19 2002 307 383
41. Singh U. DNA content analysis on microarrays Methods Mol. Biol. 270 2004 237 248
42. Serruto D. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens J. Biotechnol. 113 2004 15 32
43. Mora M. Reverse vaccinology Drug Discov. Today 8 2003 459 464
44. Kaufmann S.H.E., McMichael A.J. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis Nat. Med. 11 2005 S33 S44
45. Hovanessian A.G. The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection Immunity 21 2004 617 627
46. Labrijn A.F. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1 J. Virol. 77 2003 10557 10565
47. Cohen J. Public health High hopes and dilemmas for a cervical cancer vaccine. Science. 308 2005 618 621
48. Rose R.C. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles J. Virol. 67 1993 1936 1944
49. Zhou J. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles Virology 185 1991 251 257
50. Jodar L. Development of vaccines against meningococcal disease Lancet 359 2002 1499 1508
51. Pizza M. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing Science 287 2000 1816 1820
52. Stemmer W.P. Rapid evolution of a protein in vitro by DNA shuffling Nature 370 1994 389 391
53. Crameri A. Improved green fluorescent protein by molecular evolution using DNA shuffling Nat. Biotechnol. 14 1996 315 319
54. Chang C.C. Evolution of a cytokine using DNA family shuffling Nat. Biotechnol. 17 1999 793 797
55. Tobin M.B. Directed evolution: the 'rational' basis for 'irrational' design Curr. Opin. Struct. Biol. 10 2000 421 427
56. Punnonen J. Molecular breeding of allergy vaccines and antiallergic cytokines Int. Arch. Allergy Immunol. 121 2000 173 182
57. Sette A. A roadmap for the immunomics of category A-C pathogens Immunity 22 2005 155 161
58. Ishii K. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy Immunol. Lett. 98 2005 280 290